Affiliation:
1. Department of Burns Plastic & Maxillofacial Surgery, Royal North Shore Hospital Sydney Australia
2. Northern Clinical School University of Sydney Sydney Australia
3. Department of Anatomical Pathology Royal North Shore Hospital Sydney Australia
4. St Vincent's Clinical School University of NSW Sydney Australia
Abstract
AbstractBackgroundThe majority of cutaneous squamous cell carcinomas (cSCC) have a favourable prognosis. However, a subset of cases follow an aggressive disease course with progression to metastasis and death. Several histopathological parameters are associated with poor outcomes, but lymphovascular invasion (LVI) has not been well studied.ObjectiveTo assess the prognostic significance of LVI in cSCC and determine associations between LVI and cSCC.MethodsA retrospective review of 486 consecutive cases of cSCC over a 5‐year period from a single centre was stratified by the presence or absence of LVI. Logistic regression and multivariate survival analysis were used to determine associations of LVI and prognostic significance of LVI, respectively.FindingsLVI was present in 41 cases (9.2%). LVI was significantly associated with increasing depth of invasion, microanatomical tumour location (subcutis vs. dermis), and tumour dimensions (P < 0.05). Univariate survival analysis revealed significantly lower 2‐year overall survival rates for patients with LVI (37.1%) compared with those without (66.6%) (95% CI = 60.6–73.3, P < 0.001). LVI was also found to be an independent marker of poor disease‐specific survival (HR = 0.232 (95% CI = 0.090–0.600), P = 0.003), poor overall survival (HR 0.338 (95% CI = 0.184–0.623), P < 0.001) and poor disease‐free survival (HR 0.461 (95% CI = 0.230–0.923), P = 0.029) through multivariate analysis.ConclusionsThis study confirms that LVI is an independent poor prognosticator in cSCC, with significantly worse survival indices at 2 years. Future systems of risk stratification for cSCC should incorporate LVI.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献